2018
A Guanidine-Based Synthetic Compound Suppresses Angiogenesis via Inhibition of Acid Ceramidase
Abstract: Angiogenesis generates new blood vessels from pre-existing vessels. Tumors induce the formation of new blood vessels to ensure sufficient oxygen and nutrients for their growth. Normally, angiogenesis is induced by various pro-angiogenesis factors, including vascular endothelial growth factor (VEGF). Inhibition of VEGF is a promising approach to cancer treatment. A guanidine-based synthetic compound, E2, was identified as a potent hit from 68 guanidine-based derivatives by screening for angiogenesis inhibitors …
Search citation statements
Paper Sections
Select...
13
5
1
0
Citation Types
0
11
0
0
Year Published
Range
2019
2025
Publication Types
Select...
14
2
1
1
Relationship
1
17
Authors
Journals
Cited by 18 publications
(11 citation statements)
References 40 publications
0
11
0
0
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…It should be noted in conclusion, that chemists continue to use thiourea oxides in the synthesis of guanidine-based pharmaceuticals. Thus, in 2019 Cho and coworkers have received guanidine-based compound which suppresses angiogenesis in human umbilical vein ebdothelial cells [26]. In the intermediate steps of the synthesis of this compound they used thiourea trioxide.…”
Section: Discussion
mentioning
confidence: 99%